EQIX
48
3
MRO
46
3
WAT
36
-2
APA
24
5
SLB
56
4
ECL
62
-2
CF
42
-3
SE
55
12
V
58
-6
AAL
35
2
AZO
48
-10
MA
58
-9
UPS
46
-4
CB
53
2
IR
77
2
WHR
70
-2
PX
62
2
SRCL
60
3
HBAN
44
2
VNO
52
3
EQIX
48
3
MRO
46
3
WAT
36
-2
APA
24
5
SLB
56
4
ECL
62
-2
CF
42
-3
SE
55
12
V
58
-6
AAL
35
2
AZO
48
-10
MA
58
-9
UPS
46
-4
CB
53
2
IR
77
2
WHR
70
-2
PX
62
2
SRCL
60
3
HBAN
44
2
VNO
52
3
Financhill
Back

Repligen Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

RGEN
Repligen

Last Price:
125.92
Seasonality Move:
4.1%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Sell
49
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $126.59. The Score for RGEN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $126.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.54 Sell
Relative Strength Index (14 RSI): 33 Sell
Chaikin Money Flow: -232865 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (126.24 - 153.8) Sell
Bollinger Bands (100): (148.41 - 195.57) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 124.13 Buy
20-day SMA: 135.48 Sell
50-day SMA: 153.06 Sell
200-day SMA: 167.19 Sell
8-day EMA: 126.61 Sell
20-day EMA: 134.89 Sell
50-day EMA: 149.96 Sell
200-day EMA: 166.23 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):